SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001387308-14-000117
Filing Date
2014-08-26
Accepted
2014-08-25 20:39:24
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q (A/1) form10qa1.htm 10-Q/A 32903
2 EX 31.1 ex311.htm EX-31.1 9890
3 EX 32.1 ex321.htm EX-32.1 5823
  Complete submission text file 0001387308-14-000117.txt   857502

Data Files

Seq Description Document Type Size
4 EX 101.INS axim-20140630.xml EX-101.INS 86925
5 EX 101.SCH axim-20140630.xsd EX-101.SCH 13699
6 EX 101.CAL axim-20140630_cal.xml EX-101.CAL 10009
7 EX 101.DEF axim-20140630_def.xml EX-101.DEF 14372
8 EX 101.LAB axim-20140630_lab.xml EX-101.LAB 94668
9 EX 101.PRE axim-20140630_pre.xml EX-101.PRE 63414
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 141063588
SIC: 4953 Refuse Systems